Table 2.
Acronyms and full names of trials mentioned in this article
Short name | Full name |
---|---|
AF-CHF | Atrial Fibrillation and Congestive Heart Failure |
AFFIRM | The Atrial Fibrillation Follow-up Investigation of Rhythm Management |
BEST | Beta-Blocker Evaluation in Survival Trial |
BHAT | Beta Blocker Heart Attack Trial |
BIP | Bezafibrate Intervention Study |
CAPRICORN | Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction |
CHARISMA | Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance |
CIBIS-II | Cardiac Insufficiency Bisoprolol Study |
COMET | Carvedilol Or Metoprolol European Trial |
COMMIT | Clopidogrel and Metoprolol in Myocardial Infarction Trial |
COPERNICUS | Carvedilol Prospective Randomized Cumulative Survival |
ISIS-1 | First International Study of Infarct Survival |
J-DHF | Japanese Diastolic Heart Failure Study |
MERIT-HF | Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure |
MIAMI | Metoprolol in acute myocardial infarction |
MOCHA | Multicenter Oral Carvedilol Heart Failure Assessment |
MUSTT | Multicenter Unsustained Tachycardia Trial |
PRECISE | Percutaneous Robotically Enhanced Coronary Intervention |
SENIORS | Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure |
UKPDS | UK Prospective Diabetes Study |
β-PRESERVE | Rationale and design of the β-blocker in heart failure with normal left ventricular ejection fraction |